Cargando…

Amperometric immunosensor developed for sensitive detection of SARS-CoV-2 spike S1 protein in combined with portable device

In this present study, an amperometric immunosensor was developed based on disposable screen-printed carbon electrode (SPCE) for specific and sensitive detection of SARS-CoV-2 S1 protein. Anti-SARS-CoV-2 S1 monoclonal antibody was firstly immobilized onto the electrode surface. Then, the sandwich co...

Descripción completa

Detalles Bibliográficos
Autores principales: Erdem, Arzum, Senturk, Huseyin, Yildiz, Esma, Maral, Meltem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963973/
https://www.ncbi.nlm.nih.gov/pubmed/35395458
http://dx.doi.org/10.1016/j.talanta.2022.123422
_version_ 1784678106379845632
author Erdem, Arzum
Senturk, Huseyin
Yildiz, Esma
Maral, Meltem
author_facet Erdem, Arzum
Senturk, Huseyin
Yildiz, Esma
Maral, Meltem
author_sort Erdem, Arzum
collection PubMed
description In this present study, an amperometric immunosensor was developed based on disposable screen-printed carbon electrode (SPCE) for specific and sensitive detection of SARS-CoV-2 S1 protein. Anti-SARS-CoV-2 S1 monoclonal antibody was firstly immobilized onto the electrode surface. Then, the sandwich complex was formed by addition of S1 protein, secondary antibody and HRP-IgG, respectively. Chronoamperometry measurements were done in the presence of TMB mediator and the detection of SARS-CoV-2 S1 protein was performed by using 10 μL sample. The limit of detection (LOD) was found to be 0.19 ng/mL (equals to 24.7 amol in 10 μL sample) in the linear range of 0.5–10 ng/mL obtained in buffer medium. The applicability of this assay was investigated in the linear range of 0.5–3 ng/mL S1 protein in artificial saliva medium with the LOD as 0.13 ng/mL (equals to 16.9 amol in 10 μL sample). The selectivity study was examined in the presence of Hemagglutinin antigen (HA) in both mediums; buffer and artificial saliva while resulting with the successful discrimination between S1 protein and HA. The one of ultimate goals of our study is to present the possible implementation of this assay to point of care (POC) analysis. Under this aim, this assay was performed in combination with a portable device that is the commercial electrochemical analyzer. Amperometric detection of S1 protein in the range of 0.5–5 ng/mL was also successfully performed in artificial saliva medium with a resulting LOD as 0.15 ng/mL (equals to 19.5 amol in 10 μL sample). In addition, a selectivity study was similarly carried out by portable device.
format Online
Article
Text
id pubmed-8963973
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-89639732022-03-30 Amperometric immunosensor developed for sensitive detection of SARS-CoV-2 spike S1 protein in combined with portable device Erdem, Arzum Senturk, Huseyin Yildiz, Esma Maral, Meltem Talanta Article In this present study, an amperometric immunosensor was developed based on disposable screen-printed carbon electrode (SPCE) for specific and sensitive detection of SARS-CoV-2 S1 protein. Anti-SARS-CoV-2 S1 monoclonal antibody was firstly immobilized onto the electrode surface. Then, the sandwich complex was formed by addition of S1 protein, secondary antibody and HRP-IgG, respectively. Chronoamperometry measurements were done in the presence of TMB mediator and the detection of SARS-CoV-2 S1 protein was performed by using 10 μL sample. The limit of detection (LOD) was found to be 0.19 ng/mL (equals to 24.7 amol in 10 μL sample) in the linear range of 0.5–10 ng/mL obtained in buffer medium. The applicability of this assay was investigated in the linear range of 0.5–3 ng/mL S1 protein in artificial saliva medium with the LOD as 0.13 ng/mL (equals to 16.9 amol in 10 μL sample). The selectivity study was examined in the presence of Hemagglutinin antigen (HA) in both mediums; buffer and artificial saliva while resulting with the successful discrimination between S1 protein and HA. The one of ultimate goals of our study is to present the possible implementation of this assay to point of care (POC) analysis. Under this aim, this assay was performed in combination with a portable device that is the commercial electrochemical analyzer. Amperometric detection of S1 protein in the range of 0.5–5 ng/mL was also successfully performed in artificial saliva medium with a resulting LOD as 0.15 ng/mL (equals to 19.5 amol in 10 μL sample). In addition, a selectivity study was similarly carried out by portable device. Elsevier B.V. 2022-07-01 2022-03-29 /pmc/articles/PMC8963973/ /pubmed/35395458 http://dx.doi.org/10.1016/j.talanta.2022.123422 Text en © 2022 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Erdem, Arzum
Senturk, Huseyin
Yildiz, Esma
Maral, Meltem
Amperometric immunosensor developed for sensitive detection of SARS-CoV-2 spike S1 protein in combined with portable device
title Amperometric immunosensor developed for sensitive detection of SARS-CoV-2 spike S1 protein in combined with portable device
title_full Amperometric immunosensor developed for sensitive detection of SARS-CoV-2 spike S1 protein in combined with portable device
title_fullStr Amperometric immunosensor developed for sensitive detection of SARS-CoV-2 spike S1 protein in combined with portable device
title_full_unstemmed Amperometric immunosensor developed for sensitive detection of SARS-CoV-2 spike S1 protein in combined with portable device
title_short Amperometric immunosensor developed for sensitive detection of SARS-CoV-2 spike S1 protein in combined with portable device
title_sort amperometric immunosensor developed for sensitive detection of sars-cov-2 spike s1 protein in combined with portable device
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963973/
https://www.ncbi.nlm.nih.gov/pubmed/35395458
http://dx.doi.org/10.1016/j.talanta.2022.123422
work_keys_str_mv AT erdemarzum amperometricimmunosensordevelopedforsensitivedetectionofsarscov2spikes1proteinincombinedwithportabledevice
AT senturkhuseyin amperometricimmunosensordevelopedforsensitivedetectionofsarscov2spikes1proteinincombinedwithportabledevice
AT yildizesma amperometricimmunosensordevelopedforsensitivedetectionofsarscov2spikes1proteinincombinedwithportabledevice
AT maralmeltem amperometricimmunosensordevelopedforsensitivedetectionofsarscov2spikes1proteinincombinedwithportabledevice